Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
2.

Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.

Theodorakis MJ, Carlson O, Muller DC, Egan JM.

Diabetes Care. 2004 Jul;27(7):1692-8.

PMID:
15220248
3.

The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.

Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL.

Clin Endocrinol (Oxf). 1980 Dec;13(6):587-93.

PMID:
7014042
4.

Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL.

Am Surg. 2004 Jan;70(1):1-4; discussion 4-5.

PMID:
14964537
5.

Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism.

Osei K, Falko JM, O'Dorisio TM, Adam DR.

Diabetes Care. 1985 Sep-Oct;8(5):436-9.

PMID:
3902421
6.

The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP).

Jorde R, Burhol PG, Johnson JA.

Scand J Gastroenterol. 1981;16(2):313-9.

PMID:
7031848
7.

Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.

Jones IR, Owens DR, Luzio SD, Hayes TM.

Diabete Metab. 1989 Jan-Feb;15(1):11-22.

PMID:
2721810
8.

The effect of gastric bypass operation on glucose tolerance in obesity.

Schrumpf E, Bergan A, Djøseland O, Fausa O, Flaten O, Skagen DW, Tronier B.

Scand J Gastroenterol Suppl. 1985;107:24-31.

PMID:
3885381
9.

Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.

Crockett SE, Mazzaferri EL, Cataland S.

Diabetes. 1976 Oct;25(10):931-5.

PMID:
976601
10.

Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.

Amland PF, Jorde R, Kildebo S, Burhol PG, Giercksky KE.

Scand J Gastroenterol. 1984 Sep;19(6):857-61.

PMID:
6393318
11.

Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass.

Lauritsen KB, Christensen KC, Stokholm KH.

Scand J Gastroenterol. 1980;15(4):489-95.

PMID:
7001614
12.

Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.

Chan CB, Pederson RA, Buchan AM, Tubesing KB, Brown JC.

Diabetes. 1984 Jun;33(6):536-42.

PMID:
6373459
13.

Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.

Schattenmann G, Ebert R, Siewert R, Creutzfeldt W.

Scand J Gastroenterol. 1984 Mar;19(2):260-6.

PMID:
6372074
14.

Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.

Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Ma YZ, Sherwin RS, Caprio S.

Pediatr Res. 2000 May;47(5):628-33.

PMID:
10813588
15.

Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity.

Roust LR, Stesin M, Go VL, O'Brien PC, Rizza RA, Service FJ.

Am J Physiol. 1988 Jun;254(6 Pt 1):E767-74.

PMID:
3287953
16.

Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity.

Näslund E, Backman L, Holst JJ, Theodorsson E, Hellström PM.

Obes Surg. 1998 Jun;8(3):253-60.

PMID:
9678192
17.
18.

Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus).

Dühlmeier R, Deegen E, Fuhrmann H, Widdel A, Sallmann HP.

Comp Biochem Physiol A Mol Integr Physiol. 2001 Jun;129(2-3):563-75.

PMID:
11423326
19.

The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.

Takemura J, Seino Y, Yamamura T, Yoshiya K, Ishikawa Y, Itoh N, Imura H.

Clin Endocrinol (Oxf). 1983 Sep;19(3):345-53.

PMID:
6354520
20.

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.

Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R.

Diabetes. 1984 Oct;33(10):950-7.

PMID:
6383904

Supplemental Content

Support Center